RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Allergan Inc.

A collection of news and information related to Allergan Inc. published by this site and its partners.

Top Allergan Inc. Articles

Displaying items 34-44
  • Valeant Pharmaceuticals vows to boost its $46-billion bid for Allergan

    The heated takeover fight over Allergan Inc., the maker of Botox, continued Tuesday with the Canadian pharmaceutical company Valeant vowing to increase its $46-billion offer this month. Meanwhile, the Canadian firm's partner in the offer, activist...
  • Allergan co-founder speaks out against Valeant takeover

    The board and chief executive of Irvine takeover target Allergan Inc. heard a voice from the past Tuesday at the company's annual meeting of shareholders. Gavin S. Herbert, Allergan's co-founder and former chairman, urged the company's directors to...
  • Valeant raises offer for Allergan for 2nd time this week

    For the second time in a week, Canadian drug maker Valeant Pharmaceuticals has raised its offer to acquire Botox maker Allergan Inc. The revised offer issued Friday lifts the proposed deal's value to about $53 billion, up from Wednesday's bid of about...
  • Ackman, Valeant partnering in bid to acquire Botox maker Allergan

    Activist investor Bill Ackman is partnering with Valeant Pharmaceuticals in an attempt to buy Orange County pharmaceutical company Allergan Inc., which sells the popular wrinkle treatment Botox. Ackman’s Pershing Square Capital Management said...
  • Allergan adopts 'poison pill' defense in Valeant takeover bid

    Allergan Inc., the Irvine company that makes Botox, has adopted a "poison pill" defense that could make it more difficult for Canadian company Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman to force through a takeover bid....
  • Novartis, GSK announce multibillion-dollar overhaul of drug businesses

    Novartis, GSK announce multibillion-dollar overhaul of drug businesses
    Swiss pharmaceutical titan Novartis AG on Tuesday announced an overhaul of its operations that involved several multibillion-dollar deals with GlaxoSmithKline intended to allow Novartis to focus on its oncology business and boost profitability, the...
  • Ackman and Valeant make bid for Allergan

    Ackman and Valeant make bid for Allergan
    Activist investor Bill Ackman and his unlikely Canadian partner, Valeant Pharmaceuticals International Inc., unveiled details of their bid for Irvine pharmaceutical company Allergan Inc., which makes the popular Botox wrinkle treatment. Valeant will...
  • Zimmer to buy Biomet amid flurry of billion-dollar medical deals

    Zimmer to buy Biomet amid flurry of billion-dollar medical deals
    Orthopedic products maker Zimmer Holdings on Thursday announced it will acquire Biomet Inc. in a deal valued at $13.35 billion, including assumption of debt, the companies said.    The proposed acquisition follows a flurry of billion-dollar deals by...
  • Allergan says it 'will carefully review' Valeant offer

    Allergan Inc., the Irvine company that makes popular wrinkle treatment Botox, acknowledged Tuesday that it has received a buyout offer from Valeant Pharmaceuticals International Inc. The company said the offer from the Canadian drug maker was...
  • 800-GET-THIN surgery centers sue insurer over Lap-Band payments

    800-GET-THIN surgery centers sue insurer over Lap-Band payments
    Ten Southern California surgery centers once affiliated with the defunct 1-800-GET-THIN advertising campaign are suing UnitedHealth Group Inc. to get reimbursed for hundreds of Lap-Band weight-loss procedures. The lawsuit comes amid federal and state...
  • Allergan stock climbs amid $46-billion bid

    Canadian company Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman moved forward with their plans to acquire Botox maker Allergan Inc., offering shareholders about $46 billion and touching off what could be a contentious fight....